Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors
PHASE1CompletedINTERVENTIONAL
Enrollment
37
Participants
Timeline
Start Date
March 31, 2007
Primary Completion Date
June 30, 2010
Conditions
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic CancerStage IV Pancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG
sunitinib malate
Given orally
DRUG
gemcitabine hydrochloride
Given IV
Trial Locations (1)
44106
Case Western Reserve University, Cleveland
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00462553 - Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors | Biotech Hunter | Biotech Hunter